Brexucabtagene autoleucel 40million-200million cells/68ml dispersion for infusion bags
previously Autologous anti-CD19-transduced CD3+ cells 40million-200million cells/68ml dispersion for infusion bags
- SNOMED code
39362811000001101- Named
- Active compound
- Brexucabtagene autoleucel
- Preferred name basis
- rINN - Recommended International Non-proprietary
previously
Other
renamed due to new approved generic name available - Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 68 ml, bag
- Ingredients
- Brexucabtagene autoleucel
— 1764706 Cell
/ 1 ml
based on ingredient substance
- Form & Route
- dispersioninfusion.intravenous
Dispersion for infusion, Intravenous - Controlled drug
- No Controlled Drug Status
Products
Tecartus 40million-200million cells/68ml dispersion for infusion bags (Gilead Sciences Ltd)
in short Tecartus 40million-200million cells/68ml inf bags
previously Tecartus 40million-200millioncells/68ml dispersion for infusion bags
Tecartus 40million-200million cells/68ml dispersion for infusion bags
- SNOMED code
39358311000001104- Named
- Supplier
- Gilead Sciences Ltd
- Licensed as
- Medicines - MHRA/EMA
- EMA (European Medicines Agency) Monitoring
- ▼ Yes, black triangle marked
- Availability restrictions
- None
- Licensed route
- Intravenous
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Tecartus 40million-200million cells/68ml dispersion for infusion bags (Gilead Sciences Ltd) 1 bag39358411000001106 ref. pack | 💯 Available Legal category: POM | NHS Indicative Price £316,118 | • Hospital |
| — |
Reference packs
Brexucabtagene autoleucel 40million-200million cells/68ml dispersion for infusion bags 1 bag
- SNOMED code
39358211000001107- Quantity and unit
- 1 bag
- Packs